Found: 14
Select item for more details and to access through your institution.
Dendritic cells reduce number and function of CD4<sup>+</sup>CD25<sup>+</sup> cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1018, doi. 10.1007/s00262-004-0554-4
- By:
- Publication type:
- Article
Virosomes as new carrier system for cancer vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1005, doi. 10.1007/s00262-004-0545-5
- By:
- Publication type:
- Article
Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 978, doi. 10.1007/s00262-004-0548-2
- By:
- Publication type:
- Article
Autologous tumor vaccines processed to express a-gal epitopes: a practical approach to immunotherapy in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 935, doi. 10.1007/s00262-004-0524-x
- By:
- Publication type:
- Article
Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1051, doi. 10.1007/s00262-004-0565-1
- By:
- Publication type:
- Article
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 963, doi. 10.1007/s00262-004-0542-8
- By:
- Publication type:
- Article
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 987, doi. 10.1007/s00262-004-0547-3
- By:
- Publication type:
- Article
Generation of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1027, doi. 10.1007/s00262-004-0541-9
- By:
- Publication type:
- Article
CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1041, doi. 10.1007/s00262-004-0546-4
- By:
- Publication type:
- Article
Both soluble and membrane-bound forms of Flt3 ligand enhance tumor immunity following “suicide” gene therapy in a murine colon carcinoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 946, doi. 10.1007/s00262-004-0553-5
- By:
- Publication type:
- Article
Cancer gene therapy: new horizons in the East.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1052, doi. 10.1007/s00262-004-0563-3
- By:
- Publication type:
- Article
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 995, doi. 10.1007/s00262-004-0527-7
- By:
- Publication type:
- Article
Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 955, doi. 10.1007/s00262-004-0529-5
- By:
- Publication type:
- Article
Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1049, doi. 10.1007/s00262-004-0564-2
- By:
- Publication type:
- Article